Show news: from last 30 days (default), 60 days, 90 days, last visit or all

NICE guidelines for COPD updated

14th December 2018

NICE Guideline NG115, Chronic obstructive pulmonary disease in over 16s: diagnosis and management, has been published and replaces clinical guideline CG101 (2010).

click here to view

AWMSG approves tiotropium

14th December 2018

The All Wales Medicines Strategy Group (AWMSG) has approved the use of tiotropium (Spiriva® Respimat®) as an option for use within NHS Wales as add-on maintenance bronchodilator treatment in patients aged ≥6years with severe asthma who experienced one or more severe asthma exacerbations in the preceding year.

click here to view

Palliative Care Formulary migration to MedicinesComplete - January 2019

11th December 2018

As you will now be aware, we are making some important changes to the way you access the current on-line Palliative Care Formulary. If you are an on-line formulary subscriber you will shortly receive details about how to access your updated formulary account on MedicinesComplete in January 2019.

Please note that only access to the Palliative Care Formulary will be moving over to the MedicinesComplete platform.

The Bulletin board, Document Library, News, Surveys and the Syringe Driver Survey Database (SDSD) will continue to be available at www.palliativedrugs.com. The site will also contain a link to the Palliative Care Formulary on the MedicinesComplete platform.

Once you have received your updated login instructions you will need to complete migration to your updated account on MedicinesComplete by 1st February 2019 when access via the palliativedrugs.com site will be switched off.

If you have any questions regarding the migration then please contact hq@palliativedrugs.com

Supplementary information on cannabis-based products for medicinal use

22nd November 2018

Supplementary information has been published to clarify the status of the recent NHS England guidance to clinicians that was published on 31 October 2018 (see our news item) and provide clarification surrounding synthetic cannabinoids for medicinal use, e.g. dronabinol and nabilone.

NHS England Supplementary information

Report on action taken on ambulatory syringe drivers

22nd November 2018

The UK government has produced a report reviewing the action taken since the 2010 Safety Alert ‘Safer ambulatory syringe drivers’. This Alert highlighted safety concerns with Graseby syringe drivers and required organisations to put in place a plan within a year to discontinue their use and transition to safer ambulatory syringe drivers within five years.

click here to view

NICE consultation on cannabis-based products for medicinal use

20th November 2018

Comments are now being sought on the draft scope for the NICE guidance on cannabis-based products for medicinal use. The consultation closes on 4 December 2018.